Med Pride
CGMP Deviations; deficiencies observed during FDA inspection
Yes — there is an active recall. 9 ongoing FDA recalls mention Neomycin (28 total). Check the affected lots below.
Most common reason: cGMP deviation (10 of these recalls)
Recalls are matched by product description. A recall usually affects specific lots, not every package of Neomycin. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
CGMP Deviations; deficiencies observed during FDA inspection
CGMP Deviations; deficiencies observed during FDA inspection
CGMP Deviations; deficiencies observed during FDA inspection
CGMP Deviations; deficiencies observed during FDA inspection
CGMP Deviations; deficiencies observed during FDA inspection
CGMP Deviations; deficiencies observed during FDA inspection
CGMP Deviations
CGMP Deviations: Firm went out of business and could no longer continue stability studies.
CGMP Deviations:
CGMP Deviations: A foreign matter identified as teflon was found in the Active Pharmaceutical Ingredient (API) used in the manufacture of Neomycin Sulfate Tablets, USP 500 mg.
CGMP Deviations: products were stored outside the drug label specifications.
cGMP deviations: Temperature abuse
Failed Stability Specifications: Out of Specification (OOS) result reported for microbiological assay
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Labeling: Incorrect or missing package insert.
CGMPs Deviations: Insufficient Quality Assurance controls over critical systems in the manufacturing facility.
CGMPs Deviations: Insufficient Quality Assurance controls over critical systems in the manufacturing facility.
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of sterility assurance.
Subpotent Drug: low out of specification assay results for the bacitracin zinc ingredient.
Subpotent Drug: low out of specification assay results for the bacitracin zinc ingredient.
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured.
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.